Isoprinosine as an Immunopotentiator
Journal of Immunopharmacology · 1979
DOI: 10.3109/08923977909026379 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Immunopharmacology, 1979. Verfasst von G Renoux und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Adjuvants, Immunologic. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
Isoprinosine is a compound developed for antiviral use. The effects of isoprinosine on mouse responses to sheep red blood cells were studied over a wide range of doses, from 0.5 microgram/kg to 5 g/kg, i.p. administered at the time of i.v. immunization or as pretreatment for 7 days before antigenic stimulus. Low doses, 50 microgram/kg to 50 mg/kg, significantly increased the numbers of IgM- or IgG-spleen antibody-forming cells. Large doses, such as the LD50 (5 g/kg) or pretreatments where unable to impair mouse immune responsiveness. Isoprinosine (< 500 mg/kg/day) orally administered at time of or one day after immunization stimulated immune responses. In vitro addition of isoprinosine to spleen lymphocytes augmented PHA- or Con A-induced proliferation over a concentration range from 10 to 150 microgram/ml, whereas isoprinosine had no effect in the absence of mitogens. These data, and the lack of immunodepressing effect, suggest that there is a need for further evaluation of isoprinosine as an immunopotentiator.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Renoux, G., Renoux, M., & Guillaumin, J. M. (1979). Isoprinosine as an Immunopotentiator. Journal of Immunopharmacology. https://doi.org/10.3109/08923977909026379
Vancouver
Renoux G, Renoux M, Guillaumin JM. Isoprinosine as an Immunopotentiator. Journal of Immunopharmacology. 1979. doi:10.3109/08923977909026379
BibTeX
@article{Renoux1979,
author = {Renoux, G and Renoux, M and Guillaumin, J M},
title = {Isoprinosine as an Immunopotentiator},
journal = {Journal of Immunopharmacology},
year = {1979},
doi = {10.3109/08923977909026379}
}
EUVIMED